Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD.

American journal of kidney diseases : the official journal of the National Kidney Foundation - 1 Oct 1997

Yang W S, Min W K, Park J S, Kim S B

Abstract excerpt

Lipoprotein(a) [Lp(a)], an independent risk factor for atherosclerotic cardiovascular disease in the general population, is known to be elevated in patients with renal disease accompanied by hypoalbuminemia such as nephrotic syndrome and end-stage renal disease. In this study, the role of hypoalbuminemia in the elevation of serum Lp(a) was investigated in 20 continuous ambulatory peritoneal dialysis (CAPD)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Albumins
Share to Apolipoproteins A

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Kidney Failure, Chronic

Share to Lipoprotein(a)

Share to Lipoproteins

Share to Phenotype

Share to Serum Albumin

Source

Identifiers

PMID: 9328365
DOI: 10.1016/s0272-6386(97)90309-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD.PMID 9328365Read ↗

Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.Semantic proximity Read ↗

Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation.Semantic proximity Read ↗

Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.Semantic proximity Read ↗

Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease.Semantic proximity Read ↗

Apo(a) phenotypes and lp(a) concentrations in renal transplant patients.Semantic proximity Read ↗

Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.Semantic proximity Read ↗

Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.Semantic proximity Read ↗

Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.Semantic proximity Read ↗

Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.Semantic proximity Read ↗

Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus.Semantic proximity Read ↗

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).Semantic proximity Read ↗

Apolipoprotein(a) phenotype, albumin clearance, and plasma levels of lipoprotein(a) in peritoneal dialysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.